The amylin receptor agonism it produces slows gastric motility specifically during the postprandial window
Int J Mol Sci 21: 3550, 2020
As I go through my personal experience with InsideTracker, Im also advocating internally for other GLP-1 users
Riss, T., Niles, A., Moravec, R., Karassina, N
Bottom line: While the dual-action nature of tirzepatide is powerful, it requires more attention to hydration and nutrition to keep energy levels stable compared to single-receptor medications
If your progress seems to have slowed even before quitting Ozempic, check out why some people struggle to lose weight on semaglutide